Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Expert Review of Vaccines|October 30, 2009
Antituberculous vaccine development: a perspective for the endemic worldIndu Verma, Ajay Grover
Plos One|July 19, 2012
BAT3 regulates Mycobacterium tuberculosis protein ESAT-6-mediated apoptosis of macrophagesAjay Grover, Angelo A Izzo
Immunology|December 20, 2013
High mobility group box 1 acts as an adjuvant for tuberculosis subunit vaccinesAjay Grover, Jolynn Troudt, Chad Foster, et al.
Indian Journal of Cancer|January 12, 2022
An economic model to assess the value of triclosan-coated sutures in reducing the risk of surgical site infection in a mastectomy in IndiaNilesh S Mahajan, Reshmi Pillai, Hitesh Chopra, et al.
Protein Expression and Purification|May 24, 2006
Expression and purification of the Mycobacterium tuberculosis complex-restricted antigen CFP21 to study its immunoprophylactic potential in mouse modelAjay Grover, Mir Fayaz Ahmed, Indu Verma, et al.
Diagnostic Microbiology and Infectious Disease|October 17, 2009
Utility of a combination of RD1 and RD2 antigens as a diagnostic marker for tuberculosisMamta Kalra, Gopal Krishan Khuller, Ajay Grover, et al.
Microbes and Infection|September 12, 2006
A multivalent combination of experimental antituberculosis DNA vaccines based on Ag85B and regions of difference antigensAjay Grover, Mir Fayaz Ahmed, Balwan Singh, et al.
Cellular Microbiology|March 12, 2008
Mycobacterial infection induces the secretion of high-mobility group box 1 proteinAjay Grover, Jennifer Taylor, Jolynn Troudt, et al.
Infection and Immunity|September 10, 2009
Kinetics of the immune response profile in guinea pigs after vaccination with Mycobacterium bovis BCG and infection with Mycobacterium tuberculosisAjay Grover, Jennifer Taylor, JoLynn Troudt, et al.
Heliyon|January 30, 2023
Antibody titer levels and the effect on subsequent SARS-CoV-2 infection in a large US-based cohortAdam Sullivan, David Alfego, Pingsha Hu, et al.
Pageof 2